D-0201-2021 Class III Terminated
FDA drug recall D-0201-2021 was initiated by SCA Pharmaceuticals on Dec 17, 2020 and is designated Class III. Reason for recall: Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit The recall status is terminated (terminated Nov 2, 2021). Affected quantity: 751 syringes.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 13, 2021
- Initiation Date
- Dec 17, 2020
- Termination Date
- Nov 2, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 751 syringes
Product description
Morphine Sulfate 3 mg/3 mL in 0.9% Sodium Chloride (1mg/mL) CII, Rx Only, 3 ml Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004010025
Reason for recall
Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
Distribution pattern
Product was distributed to hospitals nationwide.
Code information
Lot # 1220023452, BUD 2/7/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0201-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026